Cargando…
COVID-19 vaccination in patients with immunity-mediated kidney disease
Vaccination against SARS-CoV-2 seems to be safe in patients with immunity-mediated kidney disease, although their immunological responses to vaccination are impaired. Further strategies, including the administration of additional vaccine doses and passive immunization with long-acting monoclonal ant...
Autores principales: | Prendecki, Maria, Willicombe, Michelle, McAdoo, Stephen P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525453/ https://www.ncbi.nlm.nih.gov/pubmed/34667284 http://dx.doi.org/10.1038/s41581-021-00502-7 |
Ejemplares similares
-
SARS-CoV-2 vaccine strategies in kidney transplant recipients
por: Prendecki, Maria, et al.
Publicado: (2023) -
Single-dose SARS-CoV-2 vaccination efficacy in the elderly
por: Prendecki, Maria, et al.
Publicado: (2021) -
SARS-CoV-2 Antibody Point-of-Care Testing in Dialysis and Kidney Transplant Patients With COVID-19
por: Prendecki, Maria, et al.
Publicado: (2020) -
Anti–glomerular basement membrane disease during the COVID-19 pandemic
por: Prendecki, Maria, et al.
Publicado: (2020) -
Severe COVID‐19 is associated with endothelial activation and abnormal glycosylation of von Willebrand factor in patients undergoing hemodialysis
por: Mobayen, Golzar, et al.
Publicado: (2021)